long term use of glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Receptor Agonists | New
Description
There was more hypoglycemia and weight gain (+1.1 kg) in the glipizide group, whereas the sitagliptin group had weight loss (-1.5 kg)
9 These studies demonstrated that GLP-1 RAs significantly improved papilledema
Standard protocols increase doses every four weeks
What other factors influence GLP-1 effectiveness
The catalog tends to shine when curation favors quality over volume
The plethora of efficacious obesity pharmacotherapies with different mechanisms of action will allow tailored treatment plans based on individuals preference, comorbidities and treatment response
